A Study to Evaluate the Efficacy and Safety of ALH-L1005 in Patients With Chronic Periodontitis

• Status: Recruiting
• Trial end date: 2021-12-01
• Target enrollment: 0
• Participant gender: All

Summary

The main objective of this study is to evaluate efficacy and safety of ALH-L1005 in patients with chronic periodontitis

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: AngioLab, Inc.

Criteria

Inclusion Criteria:

• Men or women ages 18 and over, under 79 years of age

• Patients diagnosed with chronic periodontitis

• Patients with 4 teeth and over whose pocket depth is ≥ 4 mm and clinical attachment level is ≥ 3 mm

• Patients who are voluntarily participated in clinical trial

Exclusion Criteria:

• History of antibiotic therapy within the 1 month prior to study

• Those who had undergone any dental surgical or non-surgical therapy within 3 months prior to the start of the study

• Subjects who are pregnant/ lactating

• Smokers

• Patients who take Anticoagulants or Antiplatelet Agents

• With Systemic diseases that affect periodontal conditions such as: diabetes, hypertension and diseases of immune system